| 0 |
THIRD TRIMESTER PREGNANCY |
1 |
0.1250 |
| 1 |
ANORECTAL INFECTION BACTERIAL |
1 |
0.0667 |
| 2 |
EYELID DISCOLOURATION |
2 |
0.0392 |
| 3 |
RENAL PERIVASCULAR EPITHELIOID CELL TUMOUR |
1 |
0.0385 |
| 4 |
ANAL PARAESTHESIA |
1 |
0.0345 |
| 5 |
MALIGNANT HISTIOCYTOSIS |
1 |
0.0323 |
| 6 |
ADMINISTRATION SITE URTICARIA |
1 |
0.0312 |
| 7 |
VIRAL TITRE DECREASED |
1 |
0.0278 |
| 8 |
OCULAR MELANOMA |
1 |
0.0161 |
| 9 |
COINFECTION |
1 |
0.0145 |
| 10 |
PERIORBITAL DERMATITIS |
1 |
0.0128 |
| 11 |
SWELLING OF NOSE |
2 |
0.0116 |
| 12 |
RABIES |
1 |
0.0110 |
| 13 |
MALIGNANT MELANOMA STAGE 0 |
2 |
0.0096 |
| 14 |
CAROTID ARTERY STENT INSERTION |
1 |
0.0093 |
| 15 |
IMPLANT SITE HYPERSENSITIVITY |
1 |
0.0090 |
| 16 |
OPTIC DISC OEDEMA |
1 |
0.0086 |
| 17 |
CONJUNCTIVITIS |
154 |
0.0083 |
| 18 |
SUBCORNEAL PUSTULAR DERMATOSIS |
1 |
0.0081 |
| 19 |
CUTANEOUS T-CELL LYMPHOMA |
10 |
0.0079 |
| 20 |
LARYNGEAL DYSKINESIA |
1 |
0.0078 |
| 21 |
PH BODY FLUID ABNORMAL |
1 |
0.0072 |
| 22 |
INJECTION SITE DERMATITIS |
1 |
0.0069 |
| 23 |
ENTEROBIASIS |
1 |
0.0067 |
| 24 |
PERIPANCREATIC FLUID COLLECTION |
1 |
0.0066 |
| 25 |
PERIORAL DERMATITIS |
4 |
0.0063 |
| 26 |
SCROTAL ERYTHEMA |
1 |
0.0060 |
| 27 |
INJECTION SITE EXFOLIATION |
4 |
0.0060 |
| 28 |
PROSTATIC OBSTRUCTION |
1 |
0.0060 |
| 29 |
RENAL EMBOLISM |
1 |
0.0054 |
| 30 |
ECZEMA EYELIDS |
3 |
0.0054 |
| 31 |
KERATOCONUS |
2 |
0.0053 |
| 32 |
METASTASES TO SPINAL CORD |
1 |
0.0052 |
| 33 |
TOPICAL STEROID WITHDRAWAL REACTION |
2 |
0.0051 |
| 34 |
UROGENITAL DISORDER |
1 |
0.0050 |
| 35 |
LEPROSY |
1 |
0.0048 |
| 36 |
ECZEMA HERPETICUM |
2 |
0.0043 |
| 37 |
HELMINTHIC INFECTION |
1 |
0.0041 |
| 38 |
PARAPSORIASIS |
1 |
0.0037 |
| 39 |
PUTAMEN HAEMORRHAGE |
1 |
0.0035 |
| 40 |
GENERALISED PUSTULAR PSORIASIS |
1 |
0.0034 |
| 41 |
GENITAL PARAESTHESIA |
1 |
0.0034 |
| 42 |
TRANSIENT ACANTHOLYTIC DERMATOSIS |
1 |
0.0034 |
| 43 |
PHARYNGEAL OPERATION |
1 |
0.0031 |
| 44 |
VITILIGO |
7 |
0.0030 |
| 45 |
DERMATITIS ATOPIC |
149 |
0.0028 |
| 46 |
EYELID MARGIN CRUSTING |
8 |
0.0028 |
| 47 |
ECZEMA |
135 |
0.0026 |
| 48 |
ANHIDROSIS |
1 |
0.0025 |
| 49 |
VIRAL RASH |
1 |
0.0025 |
| 50 |
EYELID IRRITATION |
6 |
0.0024 |
| 51 |
PERIORBITAL PAIN |
2 |
0.0024 |
| 52 |
SEXUALLY TRANSMITTED DISEASE |
1 |
0.0023 |
| 53 |
DERMATITIS EXFOLIATIVE GENERALISED |
8 |
0.0023 |
| 54 |
EYELIDS PRURITUS |
7 |
0.0022 |
| 55 |
INJECTION SITE DRYNESS |
2 |
0.0022 |
| 56 |
CARDIAC PACEMAKER REPLACEMENT |
1 |
0.0022 |
| 57 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
8 |
0.0021 |
| 58 |
EYELID RASH |
2 |
0.0020 |
| 59 |
REBOUND ATOPIC DERMATITIS |
4 |
0.0020 |
| 60 |
KERATITIS |
6 |
0.0020 |
| 61 |
INJECTION SITE PARAESTHESIA |
3 |
0.0020 |
| 62 |
REBOUND ECZEMA |
4 |
0.0020 |
| 63 |
EYE ALLERGY |
3 |
0.0019 |
| 64 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
50 |
0.0019 |
| 65 |
PALMOPLANTAR PUSTULOSIS |
1 |
0.0019 |
| 66 |
ASPARTATE AMINOTRANSFERASE DECREASED |
1 |
0.0019 |
| 67 |
EYE INFECTION BACTERIAL |
1 |
0.0018 |
| 68 |
EYE ULCER |
1 |
0.0017 |
| 69 |
SKIN HYPOPIGMENTATION |
3 |
0.0017 |
| 70 |
PUSTULE |
4 |
0.0017 |
| 71 |
EYELID SKIN DRYNESS |
2 |
0.0016 |
| 72 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
28 |
0.0016 |
| 73 |
NEURODERMATITIS |
6 |
0.0016 |
| 74 |
DERMATOSIS |
1 |
0.0016 |
| 75 |
INJECTION SITE LACERATION |
1 |
0.0016 |
| 76 |
EYE PRURITUS |
52 |
0.0015 |
| 77 |
NASAL CRUSTING |
1 |
0.0015 |
| 78 |
DERMATITIS PSORIASIFORM |
3 |
0.0015 |
| 79 |
CYTOKINE STORM |
1 |
0.0015 |
| 80 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 81 |
SKIN FISSURES |
28 |
0.0014 |
| 82 |
DYSHIDROTIC ECZEMA |
1 |
0.0014 |
| 83 |
ALANINE AMINOTRANSFERASE DECREASED |
1 |
0.0014 |
| 84 |
CONJUNCTIVITIS ALLERGIC |
2 |
0.0013 |
| 85 |
BLISTER RUPTURE |
1 |
0.0013 |
| 86 |
OVARIAN NEOPLASM |
1 |
0.0013 |
| 87 |
OCULAR HYPERAEMIA |
62 |
0.0013 |
| 88 |
ERYTHEMA OF EYELID |
7 |
0.0013 |
| 89 |
INFECTION PARASITIC |
1 |
0.0013 |
| 90 |
SWELLING OF EYELID |
8 |
0.0013 |
| 91 |
GROWTH OF EYELASHES |
1 |
0.0013 |
| 92 |
PNEUMONIA MYCOPLASMAL |
1 |
0.0013 |
| 93 |
SYSTEMIC LUPUS ERYTHEMATOSUS RASH |
1 |
0.0013 |
| 94 |
EYE DISCHARGE |
13 |
0.0012 |
| 95 |
HERPES ZOSTER DISSEMINATED |
1 |
0.0012 |
| 96 |
SKIN BACTERIAL INFECTION |
1 |
0.0012 |
| 97 |
ACNE PUSTULAR |
1 |
0.0012 |
| 98 |
SENSITIVE SKIN |
9 |
0.0012 |
| 99 |
INJECTION SITE COLDNESS |
1 |
0.0012 |
| 100 |
PATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0012 |
| 101 |
ABDOMINAL LYMPHADENOPATHY |
1 |
0.0012 |
| 102 |
SKIN WEEPING |
4 |
0.0011 |
| 103 |
MUSCLE SWELLING |
1 |
0.0011 |
| 104 |
PRURIGO |
1 |
0.0011 |
| 105 |
ROSACEA |
5 |
0.0011 |
| 106 |
FOREIGN BODY IN EYE |
1 |
0.0010 |
| 107 |
BLEPHARITIS |
4 |
0.0010 |
| 108 |
EYELID PAIN |
2 |
0.0010 |
| 109 |
EYE COLOUR CHANGE |
1 |
0.0010 |
| 110 |
INJECTION SITE DISCOMFORT |
10 |
0.0009 |
| 111 |
NEUROMYOPATHY |
1 |
0.0009 |
| 112 |
HALO VISION |
1 |
0.0009 |
| 113 |
SKIN HAEMORRHAGE |
13 |
0.0009 |
| 114 |
LACRIMATION INCREASED |
26 |
0.0009 |
| 115 |
SKIN WARM |
5 |
0.0009 |
| 116 |
INJECTION SITE URTICARIA |
21 |
0.0009 |
| 117 |
INJECTION SITE PAIN |
260 |
0.0008 |
| 118 |
DERMATITIS |
17 |
0.0008 |
| 119 |
EYE IRRITATION |
45 |
0.0008 |
| 120 |
HERPES SIMPLEX |
5 |
0.0008 |
| 121 |
NAIL DISCOLOURATION |
3 |
0.0008 |
| 122 |
HERPES OPHTHALMIC |
1 |
0.0008 |
| 123 |
LIP EXFOLIATION |
1 |
0.0008 |
| 124 |
SKIN DISCOMFORT |
2 |
0.0007 |
| 125 |
SKIN EXFOLIATION |
62 |
0.0007 |
| 126 |
EYE INFLAMMATION |
7 |
0.0007 |
| 127 |
SKIN DEPIGMENTATION |
1 |
0.0007 |
| 128 |
EYE DISORDER |
24 |
0.0007 |
| 129 |
CORNEAL ABRASION |
1 |
0.0007 |
| 130 |
RASH MORBILLIFORM |
2 |
0.0007 |
| 131 |
ORAL HERPES |
14 |
0.0007 |
| 132 |
JOINT INSTABILITY |
1 |
0.0007 |
| 133 |
THERAPEUTIC RESPONSE DELAYED |
2 |
0.0007 |
| 134 |
EYE INFECTION |
8 |
0.0007 |
| 135 |
PERIORBITAL SWELLING |
4 |
0.0007 |
| 136 |
MENINGITIS BACTERIAL |
1 |
0.0007 |
| 137 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 138 |
CHAPPED LIPS |
3 |
0.0007 |
| 139 |
PRURITUS |
264 |
0.0007 |
| 140 |
DRY EYE |
34 |
0.0007 |
| 141 |
EYE SWELLING |
25 |
0.0007 |
| 142 |
IMPETIGO |
1 |
0.0007 |
| 143 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
3 |
0.0007 |
| 144 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 145 |
ORAL MUCOSAL ERUPTION |
1 |
0.0007 |
| 146 |
MYELITIS |
1 |
0.0006 |
| 147 |
INJECTION SITE HYPERSENSITIVITY |
2 |
0.0006 |
| 148 |
SKIN TIGHTNESS |
3 |
0.0006 |
| 149 |
SKIN ABRASION |
3 |
0.0006 |
| 150 |
TESTICULAR PAIN |
2 |
0.0006 |
| 151 |
NASAL ULCER |
1 |
0.0006 |
| 152 |
LOSS OF THERAPEUTIC RESPONSE |
2 |
0.0006 |
| 153 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
1 |
0.0006 |
| 154 |
OCULAR DISCOMFORT |
7 |
0.0006 |
| 155 |
SKIN EROSION |
2 |
0.0006 |
| 156 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 157 |
EOSINOPHIL COUNT INCREASED |
5 |
0.0006 |
| 158 |
DRY SKIN |
79 |
0.0006 |
| 159 |
CEREBELLAR INFARCTION |
1 |
0.0006 |
| 160 |
MILIARIA |
1 |
0.0006 |
| 161 |
SPINAL CORD INJURY |
1 |
0.0006 |
| 162 |
EXTREMITY NECROSIS |
1 |
0.0006 |
| 163 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 164 |
ALOPECIA AREATA |
1 |
0.0006 |
| 165 |
THERAPEUTIC RESPONSE DECREASED |
34 |
0.0006 |
| 166 |
OPHTHALMIC HERPES ZOSTER |
1 |
0.0006 |
| 167 |
SEBORRHOEA |
2 |
0.0005 |
| 168 |
INJECTION SITE INJURY |
3 |
0.0005 |
| 169 |
HYPERTRICHOSIS |
1 |
0.0005 |
| 170 |
ERYTHEMA |
109 |
0.0005 |
| 171 |
NARCOLEPSY |
1 |
0.0005 |
| 172 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 173 |
HERPES VIRUS INFECTION |
3 |
0.0005 |
| 174 |
ANAPHYLACTOID REACTION |
2 |
0.0005 |
| 175 |
CHEST INJURY |
1 |
0.0005 |
| 176 |
THERAPEUTIC RESPONSE SHORTENED |
16 |
0.0005 |
| 177 |
SKIN INDURATION |
1 |
0.0005 |
| 178 |
ANAL PRURITUS |
1 |
0.0005 |
| 179 |
BLEPHAROSPASM |
3 |
0.0005 |
| 180 |
SLEEP DEFICIT |
1 |
0.0005 |
| 181 |
INJECTION SITE SWELLING |
36 |
0.0005 |
| 182 |
PRODUCT DISPENSING ISSUE |
2 |
0.0005 |
| 183 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 184 |
EXOPHTHALMOS |
1 |
0.0005 |
| 185 |
HORDEOLUM |
2 |
0.0005 |
| 186 |
INJECTION SITE INDENTATION |
1 |
0.0005 |
| 187 |
SKIN SWELLING |
4 |
0.0005 |
| 188 |
IMMUNOSUPPRESSION |
4 |
0.0005 |
| 189 |
DANDRUFF |
1 |
0.0005 |
| 190 |
INJECTION SITE REACTION |
31 |
0.0005 |
| 191 |
INFECTIOUS MONONUCLEOSIS |
1 |
0.0004 |
| 192 |
METASTASES TO MENINGES |
1 |
0.0004 |
| 193 |
INJECTION SITE HAEMORRHAGE |
35 |
0.0004 |
| 194 |
LICHEN PLANUS |
1 |
0.0004 |
| 195 |
RASH MACULAR |
15 |
0.0004 |
| 196 |
INJECTION SITE RASH |
13 |
0.0004 |
| 197 |
MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE |
1 |
0.0004 |
| 198 |
VARICELLA |
1 |
0.0004 |
| 199 |
BREATH ODOUR |
1 |
0.0004 |
| 200 |
RASH |
178 |
0.0004 |
| 201 |
DERMAL CYST |
1 |
0.0004 |
| 202 |
DRUG EFFECT LESS THAN EXPECTED |
6 |
0.0004 |
| 203 |
INJECTION SITE PRURITUS |
27 |
0.0004 |
| 204 |
INJECTION SITE INFLAMMATION |
2 |
0.0004 |
| 205 |
RASH ERYTHEMATOUS |
19 |
0.0004 |
| 206 |
VASODILATATION |
1 |
0.0004 |
| 207 |
SKIN BURNING SENSATION |
28 |
0.0004 |
| 208 |
INJECTION SITE INDURATION |
5 |
0.0004 |
| 209 |
SENSITIVITY TO WEATHER CHANGE |
2 |
0.0004 |
| 210 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 211 |
SCRATCH |
4 |
0.0004 |
| 212 |
COMPRESSION FRACTURE |
2 |
0.0004 |
| 213 |
INJECTION SITE DISCHARGE |
2 |
0.0004 |
| 214 |
INJECTION SITE ERYTHEMA |
46 |
0.0004 |
| 215 |
ULCERATIVE KERATITIS |
1 |
0.0004 |
| 216 |
URTICARIA |
61 |
0.0004 |
| 217 |
INJECTION SITE NODULE |
4 |
0.0004 |
| 218 |
MACULE |
1 |
0.0004 |
| 219 |
ELECTRIC SHOCK SENSATION |
1 |
0.0004 |
| 220 |
SKIN HYPERTROPHY |
1 |
0.0004 |
| 221 |
EYE PAIN |
20 |
0.0004 |
| 222 |
INJECTION SITE SCAR |
1 |
0.0004 |
| 223 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 224 |
ABORTION |
1 |
0.0003 |
| 225 |
UNDERDOSE |
25 |
0.0003 |
| 226 |
STRABISMUS |
1 |
0.0003 |
| 227 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 228 |
IRITIS |
1 |
0.0003 |
| 229 |
SKIN LESION |
9 |
0.0003 |
| 230 |
BURNING SENSATION |
23 |
0.0003 |
| 231 |
RETINAL DETACHMENT |
3 |
0.0003 |
| 232 |
PIGMENTATION DISORDER |
2 |
0.0003 |
| 233 |
PHOTOPHOBIA |
6 |
0.0003 |
| 234 |
THERAPEUTIC RESPONSE CHANGED |
2 |
0.0003 |
| 235 |
INCORRECT DOSE ADMINISTERED |
72 |
0.0003 |
| 236 |
INJECTION SITE IRRITATION |
4 |
0.0003 |
| 237 |
FOREIGN BODY SENSATION IN EYES |
2 |
0.0003 |
| 238 |
EXPOSURE VIA SKIN CONTACT |
8 |
0.0003 |
| 239 |
ANTINUCLEAR ANTIBODY POSITIVE |
1 |
0.0003 |
| 240 |
PHARYNGEAL SWELLING |
3 |
0.0003 |
| 241 |
INJECTION SITE INFECTION |
1 |
0.0003 |
| 242 |
SKIN DISORDER |
10 |
0.0003 |
| 243 |
PAIN OF SKIN |
8 |
0.0003 |
| 244 |
HEPATIC CYST |
1 |
0.0003 |
| 245 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 246 |
INJECTION SITE WARMTH |
6 |
0.0003 |
| 247 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
5 |
0.0003 |
| 248 |
FORMICATION |
2 |
0.0003 |
| 249 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 250 |
HERPES ZOSTER |
16 |
0.0003 |
| 251 |
PHARYNGITIS STREPTOCOCCAL |
3 |
0.0003 |
| 252 |
SKIN LACERATION |
3 |
0.0003 |
| 253 |
RASH PUSTULAR |
2 |
0.0003 |
| 254 |
CUTANEOUS VASCULITIS |
1 |
0.0003 |
| 255 |
INJECTION SITE MASS |
10 |
0.0003 |
| 256 |
ARTHROPOD BITE |
2 |
0.0003 |
| 257 |
SUNBURN |
2 |
0.0003 |
| 258 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 259 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 260 |
FOOD ALLERGY |
2 |
0.0003 |
| 261 |
CONCUSSION |
2 |
0.0003 |
| 262 |
RASH PRURITIC |
14 |
0.0003 |
| 263 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 264 |
HYPERSENSITIVITY |
47 |
0.0003 |
| 265 |
RHINITIS |
2 |
0.0002 |
| 266 |
FUNGAL SKIN INFECTION |
1 |
0.0002 |
| 267 |
VISION BLURRED |
34 |
0.0002 |
| 268 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 269 |
PERIPHERAL VENOUS DISEASE |
1 |
0.0002 |
| 270 |
THERAPY NON-RESPONDER |
11 |
0.0002 |
| 271 |
HYPERURICAEMIA |
1 |
0.0002 |
| 272 |
UPPER-AIRWAY COUGH SYNDROME |
2 |
0.0002 |
| 273 |
SECRETION DISCHARGE |
3 |
0.0002 |
| 274 |
DERMATITIS ALLERGIC |
3 |
0.0002 |
| 275 |
INJECTION SITE BRUISING |
19 |
0.0002 |
| 276 |
SKIN PLAQUE |
2 |
0.0002 |
| 277 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 278 |
EYE HAEMORRHAGE |
3 |
0.0002 |
| 279 |
FACIAL PAIN |
2 |
0.0002 |
| 280 |
RASH PAPULAR |
5 |
0.0002 |
| 281 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 282 |
OPTIC NEURITIS |
2 |
0.0002 |
| 283 |
INJECTION SITE PAPULE |
1 |
0.0002 |
| 284 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
4 |
0.0002 |
| 285 |
LUMBAR VERTEBRAL FRACTURE |
1 |
0.0002 |
| 286 |
SKIN DISCOLOURATION |
10 |
0.0002 |
| 287 |
EYE OPERATION |
1 |
0.0002 |
| 288 |
SYNOVIAL CYST |
1 |
0.0002 |
| 289 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 290 |
FEELING OF DESPAIR |
1 |
0.0002 |
| 291 |
RASH VESICULAR |
1 |
0.0002 |
| 292 |
GUILLAIN-BARRE SYNDROME |
1 |
0.0002 |
| 293 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 294 |
DRUG DOSE OMISSION BY DEVICE |
16 |
0.0002 |
| 295 |
THERAPY CHANGE |
2 |
0.0002 |
| 296 |
VISUAL IMPAIRMENT |
25 |
0.0002 |
| 297 |
GASTROINTESTINAL SOUNDS ABNORMAL |
1 |
0.0002 |
| 298 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 299 |
EYELID PTOSIS |
2 |
0.0002 |
| 300 |
ENDOCARDITIS |
1 |
0.0002 |
| 301 |
PERIPHERAL VASCULAR DISORDER |
1 |
0.0002 |
| 302 |
APLASTIC ANAEMIA |
1 |
0.0002 |
| 303 |
BRAIN FOG |
3 |
0.0002 |
| 304 |
OVERWEIGHT |
1 |
0.0002 |
| 305 |
HYPOACUSIS |
8 |
0.0002 |
| 306 |
GINGIVITIS |
1 |
0.0002 |
| 307 |
CONDITION AGGRAVATED |
56 |
0.0002 |
| 308 |
DRUG INEFFECTIVE |
241 |
0.0002 |
| 309 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 310 |
TREATMENT FAILURE |
15 |
0.0002 |
| 311 |
STREPTOCOCCAL INFECTION |
1 |
0.0002 |
| 312 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 313 |
SCAB |
2 |
0.0002 |
| 314 |
SKIN IRRITATION |
8 |
0.0002 |
| 315 |
MUSCULOSKELETAL DISCOMFORT |
3 |
0.0002 |
| 316 |
SKIN ATROPHY |
1 |
0.0002 |
| 317 |
VASCULITIS |
2 |
0.0002 |
| 318 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 319 |
SLEEP DISORDER |
12 |
0.0002 |
| 320 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 321 |
SYMPTOM RECURRENCE |
1 |
0.0002 |
| 322 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 323 |
DISCOMFORT |
10 |
0.0002 |
| 324 |
MENISCUS INJURY |
1 |
0.0002 |
| 325 |
TENDON RUPTURE |
2 |
0.0002 |
| 326 |
SCOLIOSIS |
1 |
0.0002 |
| 327 |
EPSTEIN-BARR VIRUS INFECTION |
1 |
0.0002 |
| 328 |
NASAL DRYNESS |
1 |
0.0002 |
| 329 |
MATERNAL EXPOSURE DURING PREGNANCY |
14 |
0.0002 |
| 330 |
GLAUCOMA |
3 |
0.0002 |
| 331 |
CARDIAC FLUTTER |
1 |
0.0002 |
| 332 |
SWELLING FACE |
10 |
0.0002 |
| 333 |
PSORIASIS |
20 |
0.0002 |
| 334 |
PRODUCT PREPARATION ISSUE |
1 |
0.0002 |
| 335 |
STAPHYLOCOCCAL INFECTION |
5 |
0.0002 |
| 336 |
UPPER RESPIRATORY TRACT INFECTION |
7 |
0.0002 |
| 337 |
CARDIAC FAILURE ACUTE |
1 |
0.0001 |
| 338 |
SKIN MASS |
1 |
0.0001 |
| 339 |
TERMINAL STATE |
1 |
0.0001 |
| 340 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 341 |
FEEDING DISORDER |
3 |
0.0001 |
| 342 |
UVEITIS |
2 |
0.0001 |
| 343 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 344 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 345 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 346 |
BLISTER |
8 |
0.0001 |
| 347 |
SKIN REACTION |
2 |
0.0001 |
| 348 |
PAPULE |
1 |
0.0001 |
| 349 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 350 |
HAND FRACTURE |
1 |
0.0001 |
| 351 |
FEAR OF INJECTION |
1 |
0.0001 |
| 352 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 353 |
TONGUE DISORDER |
1 |
0.0001 |
| 354 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 355 |
ILLNESS |
14 |
0.0001 |
| 356 |
SNEEZING |
3 |
0.0001 |
| 357 |
ASTHMA |
15 |
0.0001 |
| 358 |
PEMPHIGOID |
1 |
0.0001 |
| 359 |
THYROID DISORDER |
2 |
0.0001 |
| 360 |
TENDONITIS |
2 |
0.0001 |
| 361 |
APHTHOUS ULCER |
1 |
0.0001 |
| 362 |
APNOEA |
1 |
0.0001 |
| 363 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 364 |
FURUNCLE |
1 |
0.0001 |
| 365 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 366 |
PRODUCT PRESCRIBING ERROR |
3 |
0.0001 |
| 367 |
RENAL CYST |
1 |
0.0001 |
| 368 |
HIP FRACTURE |
4 |
0.0001 |
| 369 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 370 |
PRESYNCOPE |
3 |
0.0001 |
| 371 |
BLINDNESS |
5 |
0.0001 |
| 372 |
ARTHRALGIA |
51 |
0.0001 |
| 373 |
PHOTOSENSITIVITY REACTION |
2 |
0.0001 |
| 374 |
HEMIPLEGIA |
1 |
0.0001 |
| 375 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 376 |
SCAR |
2 |
0.0001 |
| 377 |
CARDIAC OPERATION |
1 |
0.0001 |
| 378 |
DIPLOPIA |
3 |
0.0001 |
| 379 |
HYSTERECTOMY |
1 |
0.0001 |
| 380 |
MENTAL DISORDER |
5 |
0.0001 |
| 381 |
EOSINOPHILIA |
2 |
0.0001 |
| 382 |
GRIP STRENGTH DECREASED |
1 |
0.0001 |
| 383 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 384 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 385 |
DRUG ERUPTION |
2 |
0.0001 |
| 386 |
THIRST |
2 |
0.0001 |
| 387 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
5 |
0.0001 |
| 388 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 389 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
20 |
0.0001 |
| 390 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 391 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 392 |
HIDRADENITIS |
1 |
0.0001 |
| 393 |
BRAIN NEOPLASM |
1 |
0.0001 |
| 394 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 395 |
DEMENTIA |
3 |
0.0001 |
| 396 |
WOUND |
3 |
0.0001 |
| 397 |
MIDDLE INSOMNIA |
2 |
0.0001 |
| 398 |
ACCIDENTAL EXPOSURE TO PRODUCT |
11 |
0.0001 |
| 399 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 400 |
FOOT FRACTURE |
2 |
0.0001 |
| 401 |
PRODUCT USE IN UNAPPROVED INDICATION |
26 |
0.0001 |
| 402 |
PRESCRIBED OVERDOSE |
2 |
0.0001 |
| 403 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 404 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 405 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 406 |
SINUS DISORDER |
2 |
0.0001 |
| 407 |
BRAIN INJURY |
1 |
0.0001 |
| 408 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 409 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
7 |
0.0001 |
| 410 |
DRY THROAT |
1 |
0.0001 |
| 411 |
INJURY ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 412 |
EAR DISCOMFORT |
1 |
0.0001 |
| 413 |
INFLAMMATION |
5 |
0.0001 |
| 414 |
ALOPECIA |
19 |
0.0001 |
| 415 |
TENDERNESS |
1 |
0.0001 |
| 416 |
PETECHIAE |
1 |
0.0001 |
| 417 |
NERVOUSNESS |
5 |
0.0001 |
| 418 |
FOLLICULITIS |
1 |
0.0001 |
| 419 |
PARAESTHESIA |
15 |
0.0001 |
| 420 |
BREAST PAIN |
1 |
0.0001 |
| 421 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 422 |
SKIN CANCER |
2 |
0.0001 |
| 423 |
MENSTRUATION DELAYED |
1 |
0.0001 |
| 424 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
1 |
0.0001 |
| 425 |
EXPIRED PRODUCT ADMINISTERED |
3 |
0.0001 |
| 426 |
NERVE INJURY |
1 |
0.0001 |
| 427 |
RASH MACULO-PAPULAR |
2 |
0.0001 |
| 428 |
NEOPLASM MALIGNANT |
6 |
0.0001 |
| 429 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 430 |
REBOUND EFFECT |
1 |
0.0001 |
| 431 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 432 |
MADAROSIS |
1 |
0.0001 |
| 433 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 434 |
NASAL CONGESTION |
5 |
0.0001 |
| 435 |
WRIST FRACTURE |
1 |
0.0001 |
| 436 |
LOCALISED INFECTION |
2 |
0.0001 |
| 437 |
ACCIDENTAL OVERDOSE |
3 |
0.0001 |
| 438 |
NASOPHARYNGITIS |
15 |
0.0001 |
| 439 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 440 |
AGEUSIA |
2 |
0.0001 |
| 441 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 442 |
ACNE |
6 |
0.0001 |
| 443 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 444 |
RHINORRHOEA |
5 |
0.0001 |
| 445 |
HAND DEFORMITY |
1 |
0.0001 |
| 446 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 447 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 448 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 449 |
ADVERSE REACTION |
1 |
0.0001 |
| 450 |
SWELLING |
7 |
0.0001 |
| 451 |
JOINT SWELLING |
9 |
0.0001 |
| 452 |
CONTUSION |
7 |
0.0001 |
| 453 |
PROCEDURAL PAIN |
2 |
0.0001 |
| 454 |
INFLUENZA |
8 |
0.0001 |
| 455 |
APHONIA |
1 |
0.0001 |
| 456 |
NECK PAIN |
4 |
0.0001 |
| 457 |
MASS |
1 |
0.0001 |
| 458 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 459 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 460 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 461 |
THERAPY INTERRUPTED |
5 |
0.0001 |
| 462 |
HYPOKINESIA |
1 |
0.0001 |
| 463 |
FLUSHING |
7 |
0.0001 |
| 464 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 465 |
HOT FLUSH |
5 |
0.0001 |
| 466 |
VERTIGO |
4 |
0.0001 |
| 467 |
DIABETES MELLITUS |
5 |
0.0001 |
| 468 |
LIMB DISCOMFORT |
2 |
0.0001 |
| 469 |
INSOMNIA |
17 |
0.0001 |
| 470 |
HEAD INJURY |
2 |
0.0001 |
| 471 |
PNEUMOTHORAX |
1 |
0.0001 |
| 472 |
ULCER |
1 |
0.0001 |
| 473 |
MIGRAINE |
6 |
0.0001 |
| 474 |
OBESITY |
1 |
0.0001 |
| 475 |
ABSCESS |
1 |
0.0001 |
| 476 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 477 |
DRUG INTOLERANCE |
6 |
0.0001 |
| 478 |
NIGHT SWEATS |
2 |
0.0001 |
| 479 |
VIRAL INFECTION |
2 |
0.0001 |
| 480 |
LIP SWELLING |
2 |
0.0001 |
| 481 |
CHILLS |
7 |
0.0001 |
| 482 |
FACE OEDEMA |
1 |
0.0001 |
| 483 |
THERAPY CESSATION |
3 |
0.0001 |
| 484 |
FEELING ABNORMAL |
14 |
0.0001 |
| 485 |
ABDOMINAL PAIN UPPER |
12 |
0.0001 |
| 486 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 487 |
AMENORRHOEA |
1 |
0.0001 |
| 488 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 489 |
GOUT |
1 |
0.0001 |
| 490 |
OVERDOSE |
12 |
0.0001 |
| 491 |
SYNOVITIS |
1 |
0.0001 |
| 492 |
TOOTHACHE |
1 |
0.0001 |
| 493 |
PELVIC PAIN |
1 |
0.0001 |
| 494 |
BONE DISORDER |
1 |
0.0001 |
| 495 |
MUSCLE SPASMS |
10 |
0.0001 |
| 496 |
HEADACHE |
34 |
0.0001 |
| 497 |
THINKING ABNORMAL |
1 |
0.0001 |
| 498 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 499 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 500 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 501 |
MYALGIA |
9 |
0.0001 |
| 502 |
ANXIETY |
15 |
0.0001 |
| 503 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 504 |
INCREASED APPETITE |
1 |
0.0001 |
| 505 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 506 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 507 |
EAR PAIN |
1 |
0.0001 |
| 508 |
BONE PAIN |
3 |
0.0001 |
| 509 |
KIDNEY INFECTION |
1 |
0.0001 |
| 510 |
ABORTION SPONTANEOUS |
2 |
0.0000 |
| 511 |
FULL BLOOD COUNT DECREASED |
1 |
0.0000 |
| 512 |
OFF LABEL USE |
43 |
0.0000 |
| 513 |
CHEST DISCOMFORT |
5 |
0.0000 |
| 514 |
SINUSITIS |
5 |
0.0000 |
| 515 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 516 |
INFECTION |
7 |
0.0000 |
| 517 |
TOOTH LOSS |
1 |
0.0000 |
| 518 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 519 |
MOUTH ULCERATION |
1 |
0.0000 |
| 520 |
RETCHING |
1 |
0.0000 |
| 521 |
HYPOAESTHESIA |
7 |
0.0000 |
| 522 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 523 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 524 |
HYPERHIDROSIS |
6 |
0.0000 |
| 525 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 526 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 527 |
DIZZINESS |
23 |
0.0000 |
| 528 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 529 |
MUSCULOSKELETAL STIFFNESS |
4 |
0.0000 |
| 530 |
PAIN |
28 |
0.0000 |
| 531 |
PERIPHERAL SWELLING |
7 |
0.0000 |
| 532 |
ORAL PAIN |
1 |
0.0000 |
| 533 |
THROAT IRRITATION |
2 |
0.0000 |
| 534 |
PANCREATITIS ACUTE |
1 |
0.0000 |
| 535 |
CHROMATURIA |
1 |
0.0000 |
| 536 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 537 |
BACK PAIN |
10 |
0.0000 |
| 538 |
COUGH |
12 |
0.0000 |
| 539 |
PALPITATIONS |
5 |
0.0000 |
| 540 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 541 |
NEURALGIA |
1 |
0.0000 |
| 542 |
PRODUCT DOSE OMISSION ISSUE |
12 |
0.0000 |
| 543 |
CELLULITIS |
2 |
0.0000 |
| 544 |
HOSPITALISATION |
6 |
0.0000 |
| 545 |
SKIN ULCER |
1 |
0.0000 |
| 546 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 547 |
HAEMORRHAGE |
4 |
0.0000 |
| 548 |
DEAFNESS |
1 |
0.0000 |
| 549 |
ARTHRITIS |
3 |
0.0000 |
| 550 |
GASTRITIS |
1 |
0.0000 |
| 551 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 552 |
DEHYDRATION |
5 |
0.0000 |
| 553 |
LIMB INJURY |
1 |
0.0000 |
| 554 |
MOOD ALTERED |
1 |
0.0000 |
| 555 |
INFLUENZA LIKE ILLNESS |
3 |
0.0000 |
| 556 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 557 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 558 |
FLATULENCE |
2 |
0.0000 |
| 559 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 560 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 561 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 562 |
ABDOMINAL PAIN |
8 |
0.0000 |
| 563 |
INTENTIONAL PRODUCT MISUSE |
3 |
0.0000 |
| 564 |
DYSPHONIA |
2 |
0.0000 |
| 565 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 566 |
WHEEZING |
2 |
0.0000 |
| 567 |
OESOPHAGEAL CARCINOMA |
1 |
0.0000 |
| 568 |
CATARACT |
2 |
0.0000 |
| 569 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 570 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 571 |
FATIGUE |
26 |
0.0000 |
| 572 |
IRRITABILITY |
2 |
0.0000 |
| 573 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 574 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 575 |
ALANINE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 576 |
FEMUR FRACTURE |
1 |
0.0000 |
| 577 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 578 |
CARDIAC DISORDER |
3 |
0.0000 |
| 579 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 580 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 581 |
MALAISE |
14 |
0.0000 |
| 582 |
DYSPNOEA |
18 |
0.0000 |
| 583 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 584 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 585 |
ATRIAL FIBRILLATION |
3 |
0.0000 |
| 586 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 587 |
DEPRESSION |
7 |
0.0000 |
| 588 |
NAUSEA |
24 |
0.0000 |
| 589 |
HEART RATE INCREASED |
3 |
0.0000 |
| 590 |
FALL |
10 |
0.0000 |
| 591 |
SYNCOPE |
3 |
0.0000 |
| 592 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 593 |
DIARRHOEA |
19 |
0.0000 |
| 594 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 595 |
MEMORY IMPAIRMENT |
4 |
0.0000 |
| 596 |
DELIRIUM |
1 |
0.0000 |
| 597 |
DEVICE USE ERROR |
1 |
0.0000 |
| 598 |
WEIGHT DECREASED |
8 |
0.0000 |
| 599 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 600 |
CRYING |
1 |
0.0000 |
| 601 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 602 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 603 |
CHEST PAIN |
5 |
0.0000 |
| 604 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 605 |
BLOOD PRESSURE INCREASED |
4 |
0.0000 |
| 606 |
DECREASED APPETITE |
6 |
0.0000 |
| 607 |
DISORIENTATION |
1 |
0.0000 |
| 608 |
CARDIAC FAILURE |
2 |
0.0000 |
| 609 |
THROMBOSIS |
2 |
0.0000 |
| 610 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 611 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 612 |
OSTEOPOROSIS |
1 |
0.0000 |
| 613 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 614 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 615 |
RENAL IMPAIRMENT |
2 |
0.0000 |
| 616 |
HYPERTENSION |
5 |
0.0000 |
| 617 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 618 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 619 |
COVID-19 |
4 |
0.0000 |
| 620 |
LIVER DISORDER |
1 |
0.0000 |
| 621 |
TACHYCARDIA |
2 |
0.0000 |
| 622 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 623 |
WEIGHT INCREASED |
5 |
0.0000 |
| 624 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 625 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 626 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 627 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 628 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 629 |
LUNG DISORDER |
1 |
0.0000 |
| 630 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 631 |
VOMITING |
9 |
0.0000 |
| 632 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 633 |
DEPRESSED MOOD |
1 |
0.0000 |
| 634 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 635 |
OEDEMA |
1 |
0.0000 |
| 636 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 637 |
ARTHROPATHY |
1 |
0.0000 |
| 638 |
CEREBROVASCULAR ACCIDENT |
3 |
0.0000 |
| 639 |
SURGERY |
1 |
0.0000 |
| 640 |
STOMATITIS |
1 |
0.0000 |
| 641 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 642 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 643 |
FEELING HOT |
1 |
0.0000 |
| 644 |
DEATH |
14 |
0.0000 |
| 645 |
PNEUMONIA |
5 |
0.0000 |
| 646 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 647 |
SOMNOLENCE |
3 |
0.0000 |
| 648 |
PYREXIA |
5 |
0.0000 |
| 649 |
INJURY |
1 |
0.0000 |
| 650 |
AGITATION |
1 |
0.0000 |
| 651 |
BRONCHITIS |
1 |
0.0000 |
| 652 |
DYSGEUSIA |
1 |
0.0000 |
| 653 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 654 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 655 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 656 |
CARDIAC ARREST |
1 |
0.0000 |
| 657 |
TREMOR |
2 |
0.0000 |
| 658 |
BALANCE DISORDER |
1 |
0.0000 |
| 659 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 660 |
DEVICE ISSUE |
1 |
0.0000 |
| 661 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 662 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 663 |
DYSPHAGIA |
1 |
0.0000 |
| 664 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 665 |
HYPOTENSION |
2 |
0.0000 |
| 666 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 667 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 668 |
CONSTIPATION |
2 |
0.0000 |
| 669 |
SEPSIS |
1 |
0.0000 |
| 670 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 671 |
SEIZURE |
1 |
0.0000 |
| 672 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 673 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 674 |
ASTHENIA |
3 |
0.0000 |
| 675 |
RENAL FAILURE |
1 |
0.0000 |
| 676 |
ACUTE KIDNEY INJURY |
1 |
0.0000 |
| 677 |
DRUG INTERACTION |
1 |
0.0000 |
| 678 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 679 |
ANAEMIA |
1 |
0.0000 |